Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03735797 · ClinicalTrials.gov registry record
Cancer Stem Cells in Acute Leukemia
A clinical trial of Acute Leukemia, sponsored by Sanford Health.
- Active
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT03735797: Active study of Acute Leukemia, sponsored by Sanford Health.
NCT03735797 is a study of Acute Leukemia that is active but no longer recruiting, run by Sanford Health. The registered enrollment target is 50 participants, below the 462-participant average among 37 other Acute Leukemia trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03735797, a study of Acute Leukemia, is active but no longer recruiting, sponsored by Sanford Health.
- ACTIVE NOT RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Descriptive study of acute leukemia patients. Bone marrow aspirate or peripheral blood samples will be analyzed by next-generation sequencing for novel gene signatures and variations in transcriptional and epigenetic regulatory elements such as ARID5B and SALL4 variants.
Primary Outcome
Correlation of our experimentally validated Arid5b dependent transcriptional signature with primary patient samples measured by patient ARID5B expression and polymorphisms.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Bone marrow aspirate or peripheral blood sample collection
Study Locations (1)
North Dakota
- Sanford - Fargo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-07-12 |
| Est. Completion | 2029-03-01 |
What the registry record for NCT03735797 still lists
NCT03735797 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 462-participant average among 37 other Acute Leukemia trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Acute Leukemia appearing as the primary indexed condition, and to 1 intervention - of which Bone marrow aspirate or peripheral blood sample collection is the first listed.
NCT03735797 reports a single indexed study location in North Dakota.
Frequently Asked Questions
What is clinical trial NCT03735797 about?
NCT03735797 is a clinical study titled "Cancer Stem Cells in Acute Leukemia". Descriptive study of acute leukemia patients. Bone marrow aspirate or peripheral blood samples will be analyzed by next-generation sequencing for novel gene signatures and variations in transcriptional and epigenetic regulatory elements such as ARID5B and SALL4 variants.
What is the current status of trial NCT03735797?
This trial is currently active not recruiting. The enrollment target is 50 participants. The study started on 2017-07-12. Estimated completion is 2029-03-01.
What conditions does trial NCT03735797 study?
This clinical trial studies the following conditions: Acute Leukemia.
What interventions are being tested in trial NCT03735797?
The interventions under investigation include: Bone marrow aspirate or peripheral blood sample collection (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03735797?
This trial is sponsored by Sanford Health, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03735797 being conducted?
This trial has 1 study location across North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Leukemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03735797's enrollment target sits among peer trials
50 25th of 37 higher than 11 of 37 other Acute Leukemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Leukemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant
RECRUITING · Phase 2
-
Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia
RECRUITING · NA
-
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
RECRUITING · Phase 2
-
Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft
RECRUITING · Phase 1
-
Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant
RECRUITING · Phase 2
-
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI